Capula Management LTD Gilead Sciences, Inc. Put Options Transaction History

Capula Management LTD

$9.23 Billion
Q3 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $4.14 Million - $4.73 Million	-54,500 Reduced 93.0%	4,100 $315,000
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $16.1 Million - $18.4 Million	-208,800 Reduced 78.09%	58,600 $4.86 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $6.05 Million - $8.68 Million	-97,000 Reduced 26.62%	267,400 $23 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $17.4 Million - $19.9 Million	292,400 Added 406.11%	364,400 $22.5 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $4.16 Million - $4.68 Million	72,000 New	72,000 $4.45 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $1.49 Million - $1.69 Million	-22,900 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $1.55 Million - $1.67 Million	22,900 New	22,900 $1.6 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $9.36 Million - $10.2 Million	-147,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $150,000 - $171,149	-2,500 Reduced 1.67%	147,500 $9.53 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $1.91 Million - $2.18 Million	-33,700 Reduced 18.35%	150,000 $8.74 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $3.14 Million - $3.94 Million	50,500 Added 37.91%	183,700 $11.6 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $6.13 Million - $7.12 Million	84,800 Added 175.21%	133,200 $10.2 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $3.13 Million - $4.01 Million	-50,000 Reduced 50.81%	48,400 $3.62 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $2.98 Million - $3.28 Million	48,400 Added 96.8%	98,400 $6.39 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $3.13 Million - $3.45 Million	50,000 New	50,000 $3.17 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.

Account